Boehringer Ingelheim

Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience.

Forum

About

Emerging Modalities with High Therapeutic Potential to Treat Human Diseases

Boehringer Ingelheim (the Seeker) desires partners to find and develop emerging modalities that have high potential to treat or modulate human disease.

Identification of Druggable Targets to Reverse Hearing Loss

The seeker desires the identification of molecular mechanisms that overcome such blocks and will cause human hair cells to be regenerated in a functional manner.

Boehringer Ingelheim Challenge: Understanding the Antidepressant Effect of Ketamine

The Seeker desires a working hypothesis for the rapidity of ketamine’s mechanism of action and sustained antidepressant effect.